Fezolinetant: all 27 studies that test it
Page 1 of 1. Open to participants first (7), then studies with results posted, then the rest; newest registration first within each.
- A Study to Confirm if Fezolinetant Helps to Reduce Hot Flashes in Indian Women Going Through MenopauseNot yet recruitingNCT07829653Phase 3
- A Study to Learn How Enzalutamide, Apalutamide and Bicalutamide Affect the Way Fezolinetant is Processed in Men With Prostate CancerRecruitingNCT07783282Phase 1
- Fezolinetant and Vascular Health and Brain HealthNot yet recruitingNCT07606664Phase 3
- A Trial on Fezolinetant for Vasomotor Symptoms in Men Receiving Androgen Deprivation Therapy (ADT)RecruitingNCT07568236Phase 2
- Focusing on the Menopausal Transition to Improve Mid-Life Women's HealthRecruitingNCT06975111Phase 2/3
- Fezolinetant for Treating Hot Flashes in Men With Prostate CancerRecruitingNCT06972875Phase 2
- FLASH-Breast: Evaluating the Efficacy of Fezolinetant in Reducing Vasomotor Symptoms in Women With Breast Cancer on Endocrine TherapyRecruitingNCT06917313Phase 2
- Trial to Investigate the Effect of ESN364 in Early Postmenopausal Women Suffering From Hot FlashesCompletedNCT05419908Phase 2Results posted
- A Study to Find Out How Safe Long-term Treatment With Fezolinetant is in Women With Hot Flashes Going Through MenopauseCompletedNCT04003389Phase 3Results posted
- A Study to Find Out if Fezolinetant Helps Reduce Moderate to Severe Hot Flashes in Women Going Through MenopauseCompletedNCT04003155Phase 3Results posted
- A Study to Find Out if Fezolinetant Helps Reduce Moderate to Severe Hot Flashes in Women Going Through Menopause - 2CompletedNCT04003142Phase 3Results posted
- A Dose-ranging Study of the Efficacy of ESN364 in Postmenopausal Women Suffering Vasomotor Symptoms (Hot Flashes)CompletedNCT03192176Phase 2Results posted
- A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Chinese Women Going Through MenopauseCompletedNCT06812754Phase 2
- Fezolinetant for the Improvement of Vasomotor Symptoms in Breast Cancer Patients Taking Endocrine Therapy, VENT TrialTerminatedNCT06617455Phase 2
- A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Women With Breast Cancer Who Are Having Hormone TherapyActive, not recruitingNCT06440967Phase 3
- A Study to Assess Long-term Safety of Fezolinetant Given to Japanese Women Going Through MenopauseCompletedNCT06206421Phase 3
- A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Japanese Women Going Through MenopauseCompletedNCT06206408Phase 3
- A Study to Find the Best Dose of Fezolinetant to Treat Hot Flashes in Women Going Through MenopauseCompletedNCT05034042Phase 2
- A Study of Fezolinetant to Treat Hot Flashes in Women Going Through MenopauseCompletedNCT05033886Phase 3
- A Study to Evaluate the Pharmacokinetics and Safety of Fezolinetant in Healthy Chinese Female SubjectsCompletedNCT04793204Phase 1
- A Study to Assess the Effect of Food With Fezolinetant in Healthy Female ParticipantsCompletedNCT04641260Phase 1
- A Study to Investigate the Effect of Mild and Moderate Hepatic Impairment on the Safety and Tolerability of Fezolinetant Compared to Participants With Normal Hepatic FunctionCompletedNCT04482270Phase 1
- A Study to Investigate the Effect of Renal Impairment on the Safety and Tolerability of Fezolinetant Compared to Participants With Normal Renal FunctionCompletedNCT04476849Phase 1
- A Study to Assess the Safety and Tolerability of Fezolinetant in Women Seeking Treatment for Relief of Vasomotor Symptoms (VMS) Associated With MenopauseCompletedNCT04451226Phase 3
- A Study to Assess Bioequivalence of Fezolinetant Formulations in Healthy Female ParticipantsCompletedNCT04277624Phase 1
- A Study to Find Out if Fezolinetant Helps Reduce Moderate to Severe Hot Flashes in Women in Asia Going Through MenopauseCompletedNCT04234204Phase 3
- A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ESN364 in Healthy Japanese Male and Pre- and Post-menopausal Female SubjectsCompletedNCT03436849Phase 1